Reshaping AHCs' Role in Biomedical Research
January 7, 2000
The first meeting in NHPF's biomedical research series on the public stake in biomedical research, this Forum session explored the changing roles of academic health centers (AHCs) in a reconfiguring health marketplace. First, it examined the continuum of biomedical research and AHCs' roles in its perpetuation and the problems confronting AHCs as they undergo change. Next, it looked at National Institutes of Health collaboration with AHCs and initiatives to address some of the problems AHCs face. Finally, it reviewed the private sector's dominant role in biomedical research and looked at both its cooperation and competition with AHCs in the development, adoption, evaluation, and assessment of new technologies, instruments, and drugs.
John Eisenberg, MD, Administrator, Agency for Healthcare Research and Quality; Roger E. Meyer, MD, Senior Consultant on Clinical Research, Association of American Medical Colleges; Pearl O'Rourke, Deputy Director, Office of Science Policy, National Institutes of Health; Frank E. Samuel, President, Edison BioTechnology Center, Inc.
More information available in the accompanying publication, Issue Brief No. 751.